Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

IMMUNOPLATE III RADIO IMMUNODIFFUSION

K-Number: K770548 · 1977-04-15

ApplicantHyland Therapeutic Div., Travenol Laboratories
Decision Date1977-04-15
Product CodeJZQ
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

IMMUNOPLATE III RADIO IMMUNODIFFUSION is the device name listed in this FDA 510(k) record. The listed applicant is Hyland Therapeutic Div., Travenol Laboratories. It received FDA 510(k) clearance on 1977-04-15 under 510(k) number K770548. The device is classified under product code JZQ. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the IMMUNOPLATE III RADIO IMMUNODIFFUSION?

IMMUNOPLATE III RADIO IMMUNODIFFUSION is a medical device that received FDA 510(k) clearance on 1977-04-15. The listed applicant is Hyland Therapeutic Div., Travenol Laboratories. The 510(k) number is K770548.

When did IMMUNOPLATE III RADIO IMMUNODIFFUSION receive FDA 510(k) clearance?

IMMUNOPLATE III RADIO IMMUNODIFFUSION received FDA 510(k) clearance on 1977-04-15, under 510(k) number K770548.

Who is the listed applicant for IMMUNOPLATE III RADIO IMMUNODIFFUSION?

The FDA 510(k) record lists Hyland Therapeutic Div., Travenol Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for IMMUNOPLATE III RADIO IMMUNODIFFUSION?

The FDA product code for IMMUNOPLATE III RADIO IMMUNODIFFUSION is JZQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Hyland Therapeutic Div., Travenol Laboratories as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K820835ALUMINA SILICA-ACTIVATED PARTIAL THROMK820192HAEMOPHILUS INFLUENZAE TYPE B ANTISERUMK812220NEPHELOMETRIC SOLID TURBIDITY STANDARDK810078Q-PAK THERAPEUTIC DRUG MONIT. CONTROL SK810077OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.K802610ALERT A,HDL-APOLIPOROTEIN A, TEST KIT

View all 44 devices →

Related Devices (Code: JZQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K881174RID PLATE READERThe Binding Site, Ltd.K881675IMMULON 4 FLAT BOTTOM PLATES & REMOVAWELL STRIPSDynatech Laboratories, Inc.K831811REVOLUTION RADIAL IMMUNODIFFUSION PLATECalbiochem-Behring Corp.K792699OUCHTERLONY AGAR PLATESMeridian Diagnostics, Inc.K790646HELENA QUIPLATE SYSTEMHelena LaboratoriesK761311ACCRAASSAY RID KITSMiles Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑